期刊文献+

ER、PR在乳腺癌中的表达及临床意义 被引量:2

Expressions of ER and PR in breast cancer tissues and their clinical significance
下载PDF
导出
摘要 目的:检测并分析ER和PR在乳腺癌中的表达,探讨ER、PR在内分泌治疗中的作用。方法:选取137例有完整临床和病理资料的乳腺癌患者,采用免疫组化法检测其乳腺癌组织中的ER、PR表达。结果:ER,PR阳性率分别为55.47%,51.09%,PR(+)患者,其ER大多数表达阳性;绝经后ER阳性患者较绝经前患者多;ER、PR阳性率表达与淋巴结是否转移无明显相关性。结论:ER和PR在乳腺癌组织中的存在可以预测肿瘤对激素治疗是否敏感,为临床指导辅助内分泌治疗提供有力的证据。 Objective : To study the expressions of estrogen receptors (ER) and progesterone receptors (PR) in breast cancer tissues. Methods: Total of 137 cases of breast cancer with complete clinical and pathological data were selected and tested expression of ER, PR by immunohistochemical method. Results: The expressions rates of ER,PE were 55.47% ,51.09% ,respectively. The expressions of PR was correlated with the expression of ER. A positive correlation was found between expression of PR, ER and age. The expression of ER, PR in breast cancer had no relation with metastasis of axillary lymphnode. Conclusion: ER and PR in breast cancer tissue can predict the existence of tumor is sensitive to the hormone therapy for clinical treatment guide - assisted endocrine evidence.
作者 李今 张红丽
出处 《现代肿瘤医学》 CAS 2009年第10期1877-1878,共2页 Journal of Modern Oncology
关键词 雌激素受体 孕激素受体 乳腺癌 辅助内分泌治疗 estrogen receptors progesterone receptors breast cancer adjuvanticity endocrine therapy
  • 相关文献

参考文献10

二级参考文献60

  • 1陶淑芳,马加东,曹金龙.MDR、C-erbB-2和ER、PR在乳腺癌中的表达[J].现代肿瘤医学,2004,12(6):524-526. 被引量:16
  • 2姚先莹.进一步提高乳腺癌病理诊断和预后的检测水平[J].中华病理学杂志,1994,23(6):323-326. 被引量:11
  • 3袁瑛,张苏展,吴金民,郑树.c-erb-B2、p53蛋白、雌、孕激素受体表达与腋淋巴结阴性乳腺癌病人预后关系的研究[J].肿瘤,1996,16(6):583-586. 被引量:5
  • 4王裘士.外科病理学(第二版)[M].湖北科学技术出版社,.462.
  • 5中华人民共和国卫生部医政司.中国常见恶性肿瘤诊治(乳腺分册)[M].北京:北京医科大学协和中国医科大学联合出版社,1991.22.
  • 6Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:International consensus panel on the treatment of primary breast cancer[J]. J Natl Cancer Inst, 1998,90(21 ) :1601-1608.
  • 7Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights:International consensus panel on the treatment of primary breast cancer, seventh international conference on adjuvant therapy of primary breast cancer[J]. J Clin Oncol,2001,19(18) :3817-27.
  • 8National Institutes of Health Consensus Development Conference[M]. J Nail Cancer Inst Monogr,2001,30 : 151-152.
  • 9Carlson RW, Edge SB, Theriault RL. NCCN: Breast cancer[J] ,Cancer Control,2001,8(6) :54-61.
  • 10Elary Breast Cancer Treatment Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomized trials[ J ]. Lancet, 1998,352 ( 2 ) : 930-042.

共引文献77

同被引文献21

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部